The heterogeneous pathogenesis of type 1 diabetes mellitus

J Ilonen, J Lempainen, R Veijola - Nature Reviews Endocrinology, 2019 - nature.com
Type 1 diabetes mellitus (T1DM) results from the destruction of pancreatic β-cells that is
mediated by the immune system. Multiple genetic and environmental factors found in …

Isobaric labeling-based relative quantification in shotgun proteomics

N Rauniyar, JR Yates III - Journal of proteome research, 2014 - ACS Publications
Mass spectrometry plays a key role in relative quantitative comparisons of proteins in order
to understand their functional role in biological systems upon perturbation. In this review, we …

Predicting type 1 diabetes using biomarkers

E Bonifacio - Diabetes care, 2015 - Am Diabetes Assoc
Clinical type 1 diabetes is preceded by an asymptomatic phase that can be identified by
serum islet autoantibodies. This perspective proposes that there is now sufficient evidence …

Analysis of the plasma proteome using iTRAQ and TMT‐based Isobaric labeling

R Moulder, SD Bhosale, DR Goodlett… - Mass spectrometry …, 2018 - Wiley Online Library
Over the past decade, chemical labeling with isobaric tandem mass tags, such as isobaric
tags for relative and absolute quantification reagents (iTRAQ) and tandem mass tag (TMT) …

Viruses in type 1 diabetes

H Hyöty - Pediatric diabetes, 2016 - Wiley Online Library
Environmental factors play an important role in the pathogenesis of type 1 diabetes and can
determine if a genetically susceptible individual develops the disease. Increasing evidence …

Immunological biomarkers for the development and progression of type 1 diabetes

C Mathieu, R Lahesmaa, E Bonifacio, P Achenbach… - Diabetologia, 2018 - Springer
Immune biomarkers of type 1 diabetes are many and diverse. Some of these, such as the
autoantibodies, are well established but not discriminative enough to deal with the …

Serum biomarkers for diagnosis and prediction of type 1 diabetes

L Yi, AC Swensen, WJ Qian - Translational Research, 2018 - Elsevier
Type 1 diabetes (T1D) culminates in the autoimmune destruction of the pancreatic βcells,
leading to insufficient production of insulin and development of hyperglycemia. Serum …

Clinically relevant circulating protein biomarkers for type 1 diabetes: evidence from a two-sample Mendelian randomization study

N Yazdanpanah, M Yazdanpanah, Y Wang… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE To identify circulating proteins influencing type 1 diabetes susceptibility using
Mendelian randomization (MR). RESEARCH DESIGN AND METHODS We used a large …

[HTML][HTML] Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity

ES Nakayasu, LM Bramer, C Ansong… - Cell Reports …, 2023 - cell.com
Summary Type 1 diabetes (T1D) results from autoimmune destruction of β cells. Insufficient
availability of biomarkers represents a significant gap in understanding the disease cause …

Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory

R Moulder, T Välikangas, MK Hirvonen, T Suomi… - Diabetologia, 2023 - Springer
Aims/hypothesis There is a growing need for markers that could help indicate the decline in
beta cell function and recognise the need and efficacy of intervention in type 1 diabetes …